Latest News & Updates
Other trending news you may like to read
LeonaBio Names Mark F. Kubik Chief Business Officer To Lead Licensing, Partnerships And Corporate Development As Company Pushes Phase 3 Lasofoxifene For Metastatic Breast Cancer Forward
LeonaBio appoints Mark F. Kubik as CBO to drive business development and support Phase 3 lasofoxifene progress.
Simantini Singh Deo
Rigel Appoints Veteran Pharma Executive Michael Miller To Board Of Directors
Rigel adds Michael P. Miller to its Board, bringing four decades of pharma commercial and leadership experience.
Vaibhavi M.
MetaVia Taps AI Platform To Uncover New Disease Targets For Vanoglipel, Syntekabio Collaboration Highlights Inflammation, Cancer Potential For MetaVia’s Lead Drug
MetaVia uses AI to uncover new inflammation, cardiometabolic and cancer targets for vanoglipel.
Simantini Singh Deo
Biogen Publishes DEVOTE Study Showing Benefits Of High-Dose Nusinersen In Spinal Muscular Atrophy, Highlights Faster-Loading, Higher-Dose SPINRAZA Regimen
High-dose nusinersen in DEVOTE improved motor function in SMA patients with consistent safety results.
Simantini Singh Deo
20260205181751.jpg)